Corporate governance

Our executive team has proven expertise in drug development, a strong track record of delivering shareholder value, and a dedicated focus on macrophage modulating therapies.

Our Board of Directors is comprised of seasoned experts with diverse and complementary skill sets spanning big pharma, investment banking, and drug development, ensuring strategic guidance from early stage to regulatory approval.